XML 32 R13.htm IDEA: XBRL DOCUMENT v3.22.4

Accrued Liabilities and Other Liabilities

12 Months Ended

Dec. 31, 2022

Accrued Liabilities and Other Liabilities

Accrued Liabilities and Other Liabilities

6. Accrued Liabilities and Other Liabilities

Accrued liabilities consist of the following:

​

​	​	​	​	​	​	​
​	​	December 31,		​	December 31,
(in thousands)		2022			2021
Payroll and related benefits	​	$	1,639	​	$	1,751
Clinical trial costs	​	​	1,531	​	​	727
Sponsored research	​		417	​		1,315
Lease liabilities, current portion	​	​	518	​	​	—
Operating expenses	​	​	647	​	​	656
Other	​		105	​		217
Total accrued liabilities and other liabilities	​	$	4,857	​	$	4,666

​

X

- Definition

The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a),20,24)
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_AccruedLiabilitiesCurrentAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration